EMBL-EBI's Oliver Stegle is taking a statistical approach to understanding genotype-phenotype associations.
Eisai will use Genomics' tools in its drug R&D efforts including for target selection, validation, and more.
The partners will work together to analyze genomic biomarkers collected in clinical trials and other studies.
The group has developed tables that match genotype, phenotype, and clinical recommendations to help inform therapy choices at the point of care.
Researchers used an approach called tensor generalized singular value decomposition to find prognostic copy number changes in TCGA data for ovarian cancer patients.
In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.
Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.
FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.
Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.